ICS/LABA Adherence and COPD Exacerbation
NCT02446041
·
clinicaltrials.gov ↗
COMPLETED
Status
10000
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease
Chronic Obstructive
Interventions
OTHER:
Non-Interventional Study
Sponsor
AstraZeneca
Collaborators
[object Object]